Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services
| Autor: | Kim Sweeny, Lonim Prasai Dixit, Samuel Deane, Kenneth George, Melanie Y Bertram, Bruce Rasmussen, Peter Sheehan, Jeremy A. Lauer, Dan Chisholm, Senendra Raj Upreti |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Investment strategy
Cost-Benefit Analysis International Cooperation Measures of national income and output Psychological intervention 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Return on investment Development economics Per capita medicine Humans 030212 general & internal medicine Noncommunicable Diseases health care economics and organizations Cost–benefit analysis Mortality Premature General Medicine Non-communicable disease Investment (macroeconomics) medicine.disease Models Economic Cardiovascular Diseases Business Delivery of Health Care |
| Zdroj: | The Lancet. 391:2071-2078 |
| ISSN: | 0140-6736 |
| DOI: | 10.1016/s0140-6736(18)30665-2 |
| Popis: | Summary The global burden of non-communicable diseases (NCDs) is growing, and there is an urgent need to estimate the costs and benefits of an investment strategy to prevent and control NCDs. Results from an investment-case analysis can provide important new evidence to inform decision making by governments and donors. We propose a methodology for calculating the economic benefits of investing in NCDs during the Sustainable Development Goals (SDGs) era, and we applied this methodology to cardiovascular disease prevention in 20 countries with the highest NCD burden. For a limited set of prevention interventions, we estimated that US$120 billion must be invested in these countries between 2015 and 2030. This investment represents an additional $1·50 per capita per year and would avert 15 million deaths, 8 million incidents of ischaemic heart disease, and 13 million incidents of stroke in the 20 countries. Benefit–cost ratios varied between interventions and country-income levels, with an average ratio of 5·6 for economic returns but a ratio of 10·9 if social returns are included. Investing in cardiovascular disease prevention is integral to achieving SDG target 3.4 (reducing premature mortality from NCDs by a third) and to progress towards SDG target 3.8 (the realisation of universal health coverage). Many countries have implemented cost-effective interventions at low levels, so the potential to achieve these targets and strengthen national income by scaling up these interventions is enormous. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|